Cover
Cover | Oct. 20, 2021 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment No. 1 corrects a typographical error in the first sentence of Item 1.01 which sentence is amended to read, in its entirety: “On October 20, 2021, Sigyn Therapeutics, Inc. (the “Company”) consummated, with accredited investors, the sale of 320,000 shares of Company common stock and warrants to purchase an aggregate of 320,000 shares of the Company’s common stock for gross proceeds totaling $400,000.” |
Document Period End Date | Oct. 20, 2021 |
Entity File Number | 333-204486 |
Entity Registrant Name | SIGYN THERAPEUTICS, INC. |
Entity Central Index Key | 0001642159 |
Entity Tax Identification Number | 47-2573116 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2468 Historic Decatur Road |
Entity Address, Address Line Two | Suite 140 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92106 |
City Area Code | 619.368.2000 |
Local Phone Number | 368.2000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |